Elevation Oncology shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Elevation Oncology
Tip: Access up to 7 years of quarterly data
All positions including Elevation Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elevation Oncology by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $37k | 61k | 0.60 |
| 2024-06-30 | $60k | 22k | 2.70 |
| 2024-03-31 | $704k | 137k | 5.13 |
| 2023-12-31 | $129 | 241 | 0.54 |
| 2023-09-30 | $6.6k | 10k | 0.66 |
| 2023-06-30 | $23k | 15k | 1.52 |
| 2023-03-31 | $42k | 22k | 1.88 |
| 2022-12-31 | $4.0k | 4.2k | 0.94 |